US Stock MarketDetailed Quotes

CERO CERo Therapeutics

Watchlist
  • 0.051
  • -0.006-9.98%
Close Dec 23 16:00 ET
  • 0.051
  • +0.000+0.40%
Post 17:43 ET
7.59MMarket Cap-0.01P/E (TTM)

CERo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
186.68%4.4M
113.29%5.15M
1.54M
2.41M
-30.97%2.44M
3.06%11.97M
3.53M
11.62M
Selling and administrative expenses
918.56%2.63M
99.39%2.43M
--258.01K
--1.22M
-13.30%638.35K
-14.27%2.13M
--736.28K
--2.48M
-General and administrative expense
918.56%2.63M
99.39%2.43M
--258.01K
--1.22M
-13.30%638.35K
-14.27%2.13M
--736.28K
--2.48M
Research and development costs
38.88%1.77M
127.51%2.71M
--1.28M
--1.19M
-35.63%1.8M
7.76%9.85M
--2.8M
--9.14M
Operating profit
-186.68%-4.4M
-113.29%-5.15M
-1.54M
-2.41M
30.97%-2.44M
-3.06%-11.97M
-3.53M
-11.62M
Net non-operating interest income expense
2,714.01%4.42K
-128.57%-16.98K
157
59.42K
-99.91%16
-85.60%142.12K
17.27K
986.71K
Non-operating interest income
2,714.01%4.42K
----
--157
--59.42K
-99.91%16
-85.60%142.12K
--17.27K
--986.71K
Non-operating interest expense
----
--16.98K
----
----
----
----
----
----
Other net income (expense)
-8.71%169.85K
937.56%2.72M
186.07K
261.82K
Gain on sale of security
-8.64%170K
1,007.62%2.9M
--186.07K
--261.82K
----
----
----
----
Special income (charges)
----
--447.34K
----
--0
--0
----
----
----
-Less:Other special charges
----
---447.34K
----
----
----
----
----
----
Other non- operating income (expenses)
---147
---630.78K
----
----
----
----
----
----
Income before tax
-213.33%-4.23M
-17.02%-2.45M
-1.35M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Income tax
Net income
-213.33%-4.23M
-17.02%-2.45M
-1.35M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Net income continuous Operations
-213.33%-4.23M
-17.02%-2.45M
---1.35M
---2.09M
30.64%-2.44M
-11.28%-11.83M
---3.52M
---10.63M
Minority interest income
Net income attributable to the parent company
-213.33%-4.23M
-17.02%-2.45M
-1.35M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-213.33%-4.23M
-17.02%-2.45M
-1.35M
-2.09M
30.64%-2.44M
-11.28%-11.83M
-3.52M
-10.63M
Basic earnings per share
31.35%-0.09
34.78%-0.15
-0.1311
-0.23
30.64%-0.2689
-11.28%-1.3044
-0.3876
-1.1721
Diluted earnings per share
31.35%-0.09
34.78%-0.15
-0.1311
-0.23
30.64%-0.2689
-11.28%-1.3044
-0.3876
-1.1721
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 186.68%4.4M113.29%5.15M1.54M2.41M-30.97%2.44M3.06%11.97M3.53M11.62M
Selling and administrative expenses 918.56%2.63M99.39%2.43M--258.01K--1.22M-13.30%638.35K-14.27%2.13M--736.28K--2.48M
-General and administrative expense 918.56%2.63M99.39%2.43M--258.01K--1.22M-13.30%638.35K-14.27%2.13M--736.28K--2.48M
Research and development costs 38.88%1.77M127.51%2.71M--1.28M--1.19M-35.63%1.8M7.76%9.85M--2.8M--9.14M
Operating profit -186.68%-4.4M-113.29%-5.15M-1.54M-2.41M30.97%-2.44M-3.06%-11.97M-3.53M-11.62M
Net non-operating interest income expense 2,714.01%4.42K-128.57%-16.98K15759.42K-99.91%16-85.60%142.12K17.27K986.71K
Non-operating interest income 2,714.01%4.42K------157--59.42K-99.91%16-85.60%142.12K--17.27K--986.71K
Non-operating interest expense ------16.98K------------------------
Other net income (expense) -8.71%169.85K937.56%2.72M186.07K261.82K
Gain on sale of security -8.64%170K1,007.62%2.9M--186.07K--261.82K----------------
Special income (charges) ------447.34K------0--0------------
-Less:Other special charges -------447.34K------------------------
Other non- operating income (expenses) ---147---630.78K------------------------
Income before tax -213.33%-4.23M-17.02%-2.45M-1.35M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Income tax
Net income -213.33%-4.23M-17.02%-2.45M-1.35M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Net income continuous Operations -213.33%-4.23M-17.02%-2.45M---1.35M---2.09M30.64%-2.44M-11.28%-11.83M---3.52M---10.63M
Minority interest income
Net income attributable to the parent company -213.33%-4.23M-17.02%-2.45M-1.35M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -213.33%-4.23M-17.02%-2.45M-1.35M-2.09M30.64%-2.44M-11.28%-11.83M-3.52M-10.63M
Basic earnings per share 31.35%-0.0934.78%-0.15-0.1311-0.2330.64%-0.2689-11.28%-1.3044-0.3876-1.1721
Diluted earnings per share 31.35%-0.0934.78%-0.15-0.1311-0.2330.64%-0.2689-11.28%-1.3044-0.3876-1.1721
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+2.49%
Tesla
TSLA
+2.27%
Alphabet-A
GOOGL
+1.68%
Alphabet-C
GOOG
+1.57%
Taylor Morrison Home
TMHC
+1.41%

Unlock the Full List